Blockade of the pentraxin 3/CD44 interaction attenuates lung injury‐induced fibrosis-Reference-Cited by-同舟云学术

Blockade of the pentraxin 3/CD44 interaction attenuates lung injury‐induced fibrosis

Published:2022-11 Issue:11 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Chi Jhih‐Ying¹,Hsiao Yu‐Wei¹,Liang Hsin‐Yin¹²,Huang Tang‐Hsiu³⁴,Chen Feng‐Wei⁵,Chen Chen‐Yang¹,Ko Chiung‐Yuan⁶,Cheng Chao‐Chun⁵,Wang Ju‐Ming¹²⁷⁸^ORCID

Affiliation:

1. Department of Biotechnology and Bioindustry Sciences College of Bioscience and Biotechnology National Cheng Kung University Tainan Taiwan

2. International Research Center for Wound Repair and Regeneration National Cheng Kung University Tainan Taiwan

3. Division of Chest Medicine Department of Internal Medicine National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan

4. Institute of Clinical Medicine College of Medicine National Cheng Kung University Tainan Taiwan

5. Institute of Basic Medical Sciences College of Medicine National Cheng Kung University Tainan Taiwan

6. Ph.D. Program in Medical Neuroscience College of Medical Science and Technology Taipei Medical University Taipei Taiwan

7. Graduate Institute of Medical Sciences College of Medicine Taipei Medical University Taipei Taiwan

8. Graduate Institute of Medicine College of Medicine Kaohsiung Medical University Kaohsiung Taiwan

Funder

Ministry of Science and Technology

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1099

Reference63 articles.

1. Fibrosing interstitial lung diseases: knowns and unknowns

2. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management

3. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

4. Progression of fibrosing interstitial lung disease

5. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary immune profiling reveals common inflammatory endotypes of childhood wheeze and suppurative lung disease;Mucosal Immunology;2024-06

2. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease;Journal of Autoimmunity;2024-04

3. Exosome-encapsulated lncRNA HOTAIRM1 contributes to PM2.5-aggravated COPD airway remodeling by enhancing myofibroblast differentiation;Science China Life Sciences;2024-02-07

4. Investigation of a UPR-Related Gene Signature Identifies the Pro-Fibrotic Effects of Thrombospondin-1 by Activating CD47/ROS/Endoplasmic Reticulum Stress Pathway in Lung Fibroblasts;Antioxidants;2023-11-21

5. PTX3 shapes profibrotic immune cells and epithelial/fibroblast repair and regeneration in a murine model of pulmonary fibrosis;Pathology - Research and Practice;2023-11